Evidence map›Paper›PMID 32040487›Full record

ArticlePloS one2020

Diversity of bacteriophages encoding Panton-Valentine leukocidin in temporally and geographically related Staphylococcus aureus.

Geoffrey W Coombs, Sarah L Baines, Benjamin P Howden, Krister M Swenson, Frances G O'Brien

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Emergence of a methicillin-susceptibleFrontiers in cellular and infection microbiology · 2026
    Article
  5. Science advances · 2025
    Article
  6. Antibiotics (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Decoding the evolutionary history of ST30Frontiers in microbiology · 2025
    Article
  9. Article
  10. Characterisation of PVL-PositiveAntibiotics (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Analysis of intact prophages in genomes ofFrontiers in microbiology · 2022
    Article
  16. Review
  17. Examination ofViruses · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Geoffrey W CoombsAntimicrobial Resistance and Infectious Diseases Research Laboratory, Murdoch University, Murdoch, Western Australia, Australia.
Sarah L BainesDoherty Applied Microbial Genomics, Department of Microbiology & Immunology, The University of Melbourne at The Peter Doherty Institute for Infection & Immunity, Melbourne, Victoria, Australia.
Benjamin P HowdenMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, The University of Melbourne at The Peter Doherty Institute for Infection & Immunity, Melbourne, Victoria, Australia.
Krister M SwensonLIRMM, CNRS-Univ. Montpellier, Montpellier, France.
Frances G O'BrienCurtin Health Innovation Research Institute and the School of Pharmacy & Biomedical Sciences, Curtin University, Western Australia, Australia.ORCID 0000-0003-2429-5408
Murdoch University · AUThe University of Melbourne · AUCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Production of the Panton-Valentine leukocidin (PVL) by Staphylococcus aureus is mediated via the genes lukS-PV and lukF-PV which are carried on bacteriophage ϕSa2. PVL is associated with S. aureus strains that cause serious infections and clones of community-associated methicillin-resistant S. aureus (CA-MRSA) that have additionally disseminated widely. In Western Australia (WA) the original CA-MRSA were PVL negative however, between 2005 and 2008, following the introduction of eight international PVL-positive CA-MRSA, PVL-positive WA CA-MRSA were found. There was concern that PVL bacteriophages from the international clones were transferring into the local clones, therefore a comparative study of PVL-carrying ϕSa2 prophage genomes from historic WA PVL-positive S. aureus and representatives of all PVL-positive CA-MRSA isolated in WA between 2005 and 2008 was performed. The prophages were classified into two genera and three PVL bacteriophage groups and had undergone many recombination events during their evolution. Comparative analysis of mosaic regions of selected bacteriophages using the Alignments of bacteriophage genomes (Alpha) aligner revealed novel recombinations and modules. There was heterogeneity in the chromosomal integration sites, the lysogeny regulation regions, the defence and DNA processing modules, the structural and packaging modules and the lukSF-PV genes. One WA CA-MRSA (WA518751) and one international clone (Korean Clone) have probably acquired PVL-carrying ϕSa2 in WA, however these clones did not disseminate in the community. Genetic heterogeneity made it impossible to trace the source of the PVL prophages in the other WA clones. Against this background of PVL prophage diversity, the sequence of one group, the ϕSa2USA/ϕSa2wa-st93 group, was remarkably stable over at least 20 years and associated with the highly virulent USA300 and ST93-IVa CA-MRSA lineages that have disseminated globally.

Indexed as

Bacterial ToxinsBacteriophagesCell LineageDNA, BacterialExotoxinsGenotypeGeographyLeukocidinsLysogenyMethicillin-Resistant Staphylococcus aureusMolecular EpidemiologyMultilocus Sequence TypingOpen Reading FramesProphagesVirulence FactorsWestern AustraliaBacterial ToxinsDNA, BacterialExotoxinsLeukocidinsPanton-Valentine leukocidinVirulence Factors

Identifiers

PMID32040487
PMCPMC7010278
OpenAlexW3004834539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.